Specialty chemicals manufacturer Vinati Organics reported a modest year-on-year decline in earnings for the December quarter, with net profit falling 12.2% to ₹101 crore compared with ₹115 crore in the same period last year. According to reports from CNBC TV18, revenue slipped 3.5% to ₹531 crore from ₹550 crore, reflecting a softer operating environment. The company's EBITDA declined 5.2% year-on-year to ₹157.5 crore versus ₹166 crore in Q3 last year, while operating margin eased slightly to 29.7% from 30.2%.
Last year, the company had indicated expectations for output to rise by 15% in FY26, though revenue growth is likely to be slightly lower at 10–12% due to softer product prices. As reported by CNBC TV18, Managing Director Vinati Saraf Mutreja noted that the uplift will come from capacity additions, the new acrylamide tertiary butyl sulfonic acid (ATBS) line, and recently introduced products. The company is maintaining its margin outlook at 27% to remain conservative while expanding into new markets.
Despite the earnings decline, shares of Vinati Organics Ltd ended higher on Friday, January 30, by 1.80% at ₹1,523.50 on the NSE, according to CNBC TV18. The positive market response suggests investor confidence in the company's growth strategy and future prospects despite the current quarter's performance challenges.
